Barr Pharmaceuticals, Inc. (NYSE:BRL.DL)
CAPS Rating:
A specialty pharmaceutical Company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.
A specialty pharmaceutical Company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.